Yokohama, Japan

Mitsuru Inamura

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Mitsuru Inamura in Stem Cell Research

Introduction

Mitsuru Inamura is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of stem cell research, particularly through his innovative patent that addresses the removal of pluripotent cells from culture. His work is essential for advancing medical research and therapeutic applications.

Latest Patents

Inamura holds a patent for a method of removing pluripotent cells from culture. This method provides a reliable way to eliminate undifferentiated stem cells. The process involves cultivating a cell group that includes both stem cells and somatic cells in a specific culture medium containing a photosensitizer. By irradiating the cell group with light of a specific wavelength, the pluripotent stem cells can be selectively removed. This innovation is crucial for ensuring the purity of stem cell cultures, which can include embryonic stem cells (ES cells) or induced pluripotent stem cells (iPS cells).

Career Highlights

Throughout his career, Mitsuru Inamura has worked with prominent companies in the biotechnology sector. He has been associated with Reprocell, Inc. and Sbi Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to contribute to significant advancements in stem cell technology.

Collaborations

Inamura has collaborated with notable colleagues in his field, including Shunsuke Yoshida and Tohru Tanaka. These partnerships have fostered a collaborative environment that enhances innovation and research in stem cell applications.

Conclusion

Mitsuru Inamura's contributions to stem cell research through his innovative patent demonstrate his commitment to advancing medical science. His work not only enhances our understanding of stem cells but also paves the way for future therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…